Clearbridge Health Statistics

Total Valuation

SGXC:1H3 has a market cap or net worth of SGD 6.51 million. The enterprise value is 9.69 million.

Market Cap	6.51M
Enterprise Value	9.69M

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

SGXC:1H3 has 2.17 billion shares outstanding. The number of shares has increased by 11.07% in one year.

Current Share Class	n/a
Shares Outstanding	2.17B
Shares Change (YoY)	+11.07%
Shares Change (QoQ)	+10.96%
Owned by Insiders (%)	16.26%
Owned by Institutions (%)	0.55%
Float	1.67B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.21
PB Ratio	0.61
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.69
EV / Sales	0.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.57

Financial Position

The company has a current ratio of 0.87, with a Debt / Equity ratio of 0.56.

Current Ratio	0.87
Quick Ratio	0.76
Debt / Equity	0.56
Debt / EBITDA	n/a
Debt / FCF	-2.94
Interest Coverage	-5.86

Financial Efficiency

Return on equity (ROE) is -34.63% and return on invested capital (ROIC) is -12.98%.

Return on Equity (ROE)	-34.63%
Return on Assets (ROA)	-10.99%
Return on Invested Capital (ROIC)	-12.98%
Return on Capital Employed (ROCE)	-32.98%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	121
Asset Turnover	0.44
Inventory Turnover	14.72

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.00% in the last 52 weeks. The beta is 0.69, so SGXC:1H3's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-70.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	41.65
Average Volume (20 Days)	1,457,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:1H3 had revenue of SGD 9.90 million and -3.61 million in losses. Loss per share was -0.01.

Revenue	9.90M
Gross Profit	4.74M
Operating Income	-3.97M
Pretax Income	-4.14M
Net Income	-3.61M
EBITDA	-3.67M
EBIT	-3.97M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 4.89 million in cash and 6.24 million in debt, giving a net cash position of -1.35 million or -0.00 per share.

Cash & Cash Equivalents	4.89M
Total Debt	6.24M
Net Cash	-1.35M
Net Cash Per Share	-0.00
Equity (Book Value)	11.05M
Book Value Per Share	0.00
Working Capital	-1.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.98 million and capital expenditures -140,000, giving a free cash flow of -2.12 million.

Operating Cash Flow	-1.98M
Capital Expenditures	-140,000
Free Cash Flow	-2.12M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 47.88%, with operating and profit margins of -40.07% and -36.43%.

Gross Margin	47.88%
Operating Margin	-40.07%
Pretax Margin	-41.86%
Profit Margin	-36.43%
EBITDA Margin	-37.05%
EBIT Margin	-40.07%
FCF Margin	n/a

Dividends & Yields

SGXC:1H3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.07%
Shareholder Yield	-11.07%
Earnings Yield	-55.46%
FCF Yield	-32.57%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:1H3 has an Altman Z-Score of -5.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.73
Piotroski F-Score	n/a